Skip to main content

Table 3 Breast cancer risk in relation to selected SNPs with regard to parity

From: Genetic predisposition, parity, age at first childbirth and risk for breast cancer

Rs nr (Gene)

p-value inter-action

Case/ control N

Nulliparous OR* (CI 95%)

Case/ control N

Parous OR* (CI 95%)

rs2981582 (FGFR2)

0.96

    

CC

 

30/52

1.00

200/493

1.00

CT

 

36/69

0.90 (0.48-1.69)

310/571

1.36 (1.09-1.69)

TT

 

16/15

1.88 (0.78-4.52)

104/167

1.55 (1.15-2.10)

Per allele

  

1.25 (0.82-1.91)

 

1.27 (1.10-1.46)

rs1045485 (CASP8)

0.93

    

CC

 

21/48

1.00

162/318

1.00

CG

 

7/14

1.08 (0.37-3.18)

35/71

1.03 (0.65-1.63)

GG

 

0/0

---

8/10

1.68 (0.64-4.42)

Per allele

  

0.93 (0.31-2.83)

 

1.12 (0.79-1.58)

rs3803662 (TNRC9)

0.58

    

CC

 

36/72

1.00

311/694

1.00

CT

 

33/54

1.32 (0.71-2.44)

238/446

1.17 (0.95-1.47)

TT

 

8/7

1.95 (0.61-6.29)

54/82

1.47 (1.01-2.14)

Per allele

  

1.33 (0.83-2.14)

 

1.19 (1.02-1.40)

rs8051542 (TNRC9)

0.15

    

CC

 

14/38

1.00

177/399

1.00

CT

 

41/66

1.56 (0.73-3.36)

289/558

1.14 (0.91-1.44)

TT

 

23/28

2.18 (0.93-5.14)

120/234

1.14 (0.86-1.52)

Per allele

  

1.47 (0.96-2.24)

 

1.08 (0.94-1.24)

rs12443621 (TNRC9)

0.95

    

AA

 

22/30

1.00

170/415

1.00

AG

 

35/79

0.68 (0.33-1.42)

295/565

1.28 (1.02-1.62)

GG

 

25/25

1.55 (0.67-3.61)

135/237

1.43 (1.08-1.89)

Per allele

  

1.25 (0.82-1.92)

 

1.20 (1.04-1.38)

rs889312 (MAP3K1)

0.11

    

AA

 

42/67

1.00

273/653

1.00

AC

 

33/59

0.83 (0.46-1.53)

261/461

1.31 (1.06-1.62)

CC

 

4/10

0.49 (0.14-1.77)

61/103

1.47 (1.03-2.09)

Per allele

  

0.77 (0.48-1.24)

 

1.24 (1.07-1.45)

rs3817198 (LSP1)

0.48

    

TT

 

37/68

1.00

271/591

1.00

CT

 

31/55

1.12 (0.60-2.11)

239/482

1.06 (0.85-1.31)

CC

 

8/4

4.38 (1.13-16.96)

68/100

1.48 (1.04-207)

Per allele

  

1.53 (0.93-2.51)

 

1.16 (0.99-1.35)

rs2107425 (H19)

0.12

    

CC

 

44/57

1.00

311/570

1.00

CT

 

27/57

0.54 (0.28-1.05)

213/498

0.80 (0.65-1.00)

TT

 

4/14

0.35 (0.11-1.19)

64/127

0.94 (0.67-1.31)

Per allele

  

0.58 (0.36-0.95)

 

0.91 (0.78-1.06)

rs13281615 (8q24)

1.00

    

AA

 

29/52

1.00

211/465

1.00

AG

 

37/61

1.11 (0.58-2.15)

290/558

1.18 (0.95-1.47)

GG

 

13/19

1.32 (0.55-3.15)

99/183

1.26 (0.93-1.70)

Per allele

  

1.14 (0.75-1.73)

 

1.13 (0.98-1.31)

rs981782 (5p12)

0.02

    

TT

 

15/38

1.00

162/290

1.00

TG

 

43/72

1.67 (0.79-3.53)

303/595

0.85 (0.67-1.09)

GG

 

14/16

2.66 (0.99-7.12)

107/273

0.65 (0.48-0.87)

Per allele

  

1.64 (1.01-2.67)

 

0.81 (0.70-0.94)

rs30099 (5q)

0.47

    

CC

 

66/101

1.00

505/1015

1.00

CT

 

14/34

0.68 (0.32-1.43)

97/205

0.95 (0.73-1.24)

TT

 

2/1

3.18 (0.26-39.46)

9/11

1.63 (0.66-4.06)

Per allele

  

0.89 (0.47-1.67)

 

1.02 (0.81-1.30)

rs4666451 (2p)

0.37

    

GG

 

26/51

1.00

237/494

1.00

GA

 

38/54

1.39 (0.69-2.59)

256/502

1.08 (0.87-1.34)

AA

 

15/20

1.30 (0.54-3.10)

88/180

1.02 (0.75-1.38)

Per allele

  

1.17 (0.77-1.79)

 

1.02 (0.89-1.18)

rs13387042 (2q35)

0.79

    

AA

 

22/35

1.00

164/292

1.00

AG

 

40/60

1.11 (0.55-2.25)

287/580

0.87 (0.68-1.11)

GG

 

16/36

0.69 (0.30-1.61)

140/308

0.80 (0.60-1.06)

Per allele

  

0.85 (0.56-1.28)

 

0.89 (0.78-1.03)

rs7766585 (ESR1)

0.10

    

CC

 

63/97

1.00

443/907

1.00

CT

 

18/33

0.76 (0.39-1.51)

150/310

0.99 (0.79-1.24)

TT

 

0/6

----

17/20

1.91 (0.98-3.71)

Per allele

  

0.96 (0.82-1.12)

 

1.03 (0.97-1.10)

  1. *Adjusted for: age, year of inclusion in study, socioeconomic status and exposure to HRT.